Elanco Animal Health (ELAN) Short term Debt (2018 - 2026)
Elanco Animal Health (ELAN) posted Short term Debt of $73.0 million for Q1 2026, down 1.35% sequentially from $74.0 million in Q4 2025, and up 65.91% YoY from $44.0 million in Q1 2025.
Elanco Animal Health (ELAN) Short term Debt (2018 - 2026) Analysis & Trends
Elanco Animal Health has reported Short term Debt for 9 years, with the latest figure at $73.0 million in Q1 2026.
- Quarterly Short term Debt rose 65.91% year-over-year to $73.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.0 million (up 65.91% YoY) and the FY2025 annual result came in at $74.0 million, up 68.18% from the prior year.
- Short term Debt retreated to $73.0 million in Q1 2026 per ELAN's latest filing, from $74.0 million in the prior quarter.
- Over five years, Short term Debt peaked at $394.0 million in Q3 2022 and troughed at $38.0 million in Q4 2023.
- A 5-year average of $120.5 million and a median of $61.0 million in 2022 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2022 and 2023: Short term Debt soared 545.9% in 2022, then plunged 90.21% in 2023.
- Over 5 years, Short term Debt stood at $388.0 million in 2022, then slumped by 90.21% to $38.0 million in 2023, then gained by 15.79% to $44.0 million in 2024, then soared by 68.18% to $74.0 million in 2025, then fell by 1.35% to $73.0 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $73.0 million, $74.0 million, and $62.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.00 Mn |
| Mar 31, 2026 | 73.00 Mn |
| Dec 31, 2025 | 74.00 Mn |
| Sep 30, 2025 | 62.00 Mn |
| Jun 30, 2025 | 61.00 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Dec 31, 2024 | 44.00 Mn |
| Sep 30, 2024 | 44.00 Mn |
| Jun 30, 2024 | 213.00 Mn |
| Mar 31, 2024 | 38.00 Mn |
| Dec 31, 2023 | 38.00 Mn |
| Sep 30, 2023 | 39.00 Mn |
| Jun 30, 2023 | 39.00 Mn |
| Mar 31, 2023 | 381.00 Mn |
| Dec 31, 2022 | 388.00 Mn |
| Sep 30, 2022 | 394.00 Mn |
| Jun 30, 2022 | 56.00 Mn |
| Mar 31, 2022 | 61.00 Mn |
| Dec 31, 2021 | 294.00 Mn |
| Sep 30, 2021 | 61.00 Mn |